Crossmark Global Holdings, Inc. Argenx Se Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Argenx Se stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 9,462 shares of ARGX stock, worth $5.91 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

9,462

Previous 4,721 100.42%

Holding current value

$5.91 Million

Previous $2.03 Million 152.58%

% of portfolio

0.09%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$434.22 - $551.9 $2.06 Million - $2.62 Million	4,741 Added 100.42%	9,462 $5.13 Million
Q2 2024 Jul 29, 2024	SELL	$356.01 - $451.55 $101,818 - $129,143	-286 Reduced 5.71%	4,721 $2.03 Million
Q1 2024 May 13, 2024	SELL	$356.95 - $413.29 $61,395 - $71,085	-172 Reduced 3.32%	5,007 $1.97 Million
Q4 2023 Feb 13, 2024	SELL	$338.91 - $506.01 $54,225 - $80,961	-160 Reduced 3.0%	5,179 $1.97 Million
Q3 2023 Nov 08, 2023	SELL	$369.35 - $548.43 $322,811 - $479,327	-874 Reduced 14.07%	5,339 $2.67 Million
Q2 2023 Jul 31, 2023	BUY	$360.14 - $422.58 $75,269 - $88,319	209 Added 3.48%	6,213 $3.2 Million
Q1 2023 May 12, 2023	BUY	$334.23 - $403.65 $200,872 - $242,593	601 Added 11.12%	6,004 $2.24 Million
Q4 2022 Jan 19, 2023	SELL	$342.17 - $402.31 $48,588 - $57,128	-142 Reduced 2.56%	5,403 $2.05 Million
Q3 2022 Nov 01, 2022	SELL	$343.2 - $395.75 $60,746 - $70,047	-177 Reduced 3.09%	5,545 $1.96 Million
Q2 2022 Jul 29, 2022	BUY	$269.58 - $378.88 $31,001 - $43,571	115 Added 2.05%	5,722 $2.17 Million
Q1 2022 May 11, 2022	BUY	$254.45 - $351.06 $135,621 - $187,114	533 Added 10.5%	5,607 $1.77 Million
Q4 2021 Jan 10, 2022	SELL	$272.01 - $353.03 $160,757 - $208,640	-591 Reduced 10.43%	5,074 $1.78 Million
Q3 2021 Oct 21, 2021	BUY	$295.0 - $350.58 $1.67 Million - $1.99 Million	5,665 New	5,665 $1.71 Million
Q3 2021 Oct 13, 2021	SELL	$295.0 - $350.58 $1.55 Million - $1.84 Million	-5,260 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$257.11 - $319.92 $46,794 - $58,225	-182 Reduced 3.34%	5,260 $1.58 Million
Q1 2021 Apr 15, 2021	SELL	$268.3 - $380.31 $59,026 - $83,668	-220 Reduced 3.89%	5,442 $1.5 Million
Q4 2020 Jan 14, 2021	BUY	$248.13 - $308.36 $44,415 - $55,196	179 Added 3.26%	5,662 $1.67 Million
Q3 2020 Oct 08, 2020	SELL	$215.51 - $272.51 $41,377 - $52,321	-192 Reduced 3.38%	5,483 $1.44 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $723,222 - $1.32 Million	5,675 New	5,675 $1.28 Million

Others Institutions Holding ARGX

# of Institutions

401

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Argenx Se Transaction History